Navigation Links
BioMarin's Chief Executive Jean-Jacques Bienaime to Receive Most Admired CEO Award From San Francisco Business Times
Date:10/9/2009

NOVATO, Calif., Oct. 9 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that its Chief Executive Officer Jean-Jacques Bienaime will receive the Most Admired CEO Award from the San Francisco Business Times at a gala event to be held on November 19, 2009 in San Francisco. Mr. Bienaime is recognized for his outstanding leadership in the category of public companies with annual revenues of less than $500 million. Mr. Bienaime was selected by an independent panel of judges who considered multiple nominations for CEOs who consistently demonstrate excellent leadership of their companies, people, industries and communities. An advisory panel considered qualities including leadership, values, vision, company's financial performance, commitment to quality and diversity, work environment, community contributions, innovation and overcoming adversity.

"It is no coincidence that BioMarin has been named one of the San Francisco Bay Area's 'Best Places to Work'* for three consecutive years," said Mark Wood, BioMarin Vice President of Human Resources. "Mr. Bienaime has been the driving force behind the company's growth and success in recent years. Under his leadership, BioMarin has emerged as a leading fully integrated biopharmaceutical company, with an employee population that has doubled since his arrival, with employees in 20 countries worldwide."

During his five-year tenure at the company, Mr. Bienaime and his team have built BioMarin's market capitalization to highs of more than $3.5 billion, and revenues from $18.6 million to more than $300 million. The company has brought three biopharmaceutical products to market in just three to five years each, which is a remarkable accomplishment in the pharmaceutical industry where drug candidates typically require 10-12 years to progress from research to comme
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Dr. Audrey F. Jakubowski of SuperGen Retires as Chief Regulatory and Quality Officer
2. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
3. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
4. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
5. Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc.
6. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
7. China Technology Announces New Chief Financial Officer
8. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
9. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
10. GeneNews Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book
11. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , July 29, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: ... the Company,s Chief Financial Officer has resigned.  The Company ... Financial Officer who retired in December 2014, as full ... a permanent successor.     Andy Ashworth ... and ensure a smooth transition.  Andy was the Company,s ...
(Date:7/29/2015)... 2015 Research and ... of the "Global Biosimilars Market, 2015 - ... The Global Biosimilars Market, 2015 - 2025, report ... biosimilars market. With the blockbuster biologics losing patent ... biosimilars are being viewed as viable substitutes to ...
(Date:7/29/2015)... DIEGO , July 29, 2015  Pfenex Inc. ... 2015 financial results will be released on Thursday, August ... am Eastern Time, Pfenex management will host a conference ... business update.  A press release outlining the financial results ... the call. Please call 1-866-376-8058 (US) or ...
(Date:7/29/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS ) ... optimized Erk inhibitor molecule for development, thus achieving ... new class of potential cancer therapies. ... for therapeutic intervention in cancer. Recently approved compounds ... B-Raf and Mek inhibitors. Erk inhibitors may be ...
Breaking Biology Technology:BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3
... Cedara Software , a Merge Healthcare ... has released a new version of its digital imaging ... product is a software development kit (SDK) that now ... connectivity for software applications. , ,DICOM is a set ...
... your building technologically obsolete? Are you paying too much ... a building is very important in the selection process ... to current tenants who are contemplating a move to ... some should be avoided because they offer nothing in ...
... all relevant domain names and misspellings pertaining to its trademark? ... are they free for the taking? Who has rights to ... questions posed by a reader regarding domains in his portfolio. ... principles can be used as guidelines with respect to whether ...
Cached Biology Technology:Making sure YourSpace is technologically sound 2Making sure YourSpace is technologically sound 3Making sure YourSpace is technologically sound 4Making sure YourSpace is technologically sound 5Is your business domain at risk? 2Is your business domain at risk? 3Is your business domain at risk? 4
(Date:7/8/2015)... , July 8, 2015  Trovagene, Inc. (NASDAQ: ... diagnostics, today announced the launch of a study ... Precision Cancer Monitoring℠ (PCM) technology for predicting response ... or a combination of the novel immunotherapy agents ... a PD-1 inhibitor. The 50-patient study will be ...
(Date:7/7/2015)... July 7, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... growing mobile commerce market announces a revised version of one of ... commercial will air on CNBC in New York ... and San Francisco metro areas.    ... on Wocket,s ability to replace all the cards in your wallet ...
(Date:6/30/2015)... -- To bolster its efforts and commitment to fighting cyber ... addition of two new team members. ... David Raviv will act as head of strategic alliances. ... providing the most secure solutions for the enterprise market. ... Technologies, a provider of security and management products, which was ...
Breaking Biology News(10 mins):Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3
... behavior through tiny hairs on the cell surface called cilia. ... not work properly. New research from UC Davis published this ... new insights into how these cilia are assembled. "It,s ... Jonathan Scholey, professor of molecular and cellular biology at UC ...
... Iowa - Bone is one of nature,s surprising "building ... resilient. Scientists at the U.S. Department of Energy,s ... its outstanding properties and the important role citrate plays, ... or prevent bone diseases such as osteoporosis. Using ...
... The world,s largest and least known type of gorilla ... has awarded the Wildlife Conservation Society a $150,000 grant to ... eastern Democratic Republic of Congo. The grant will ... struggle to protect the gorillas of Kahuzi-Biega National Park, a ...
Cached Biology News:How cells' sensing hairs are made 2Citrate key in bone's nanostructure 2Citrate key in bone's nanostructure 3Wildlife Conservation Society receives $150,000 grant from Newman's Own Foundation to save gorillas 2